About Us
Soiken Group—Commercializing the outcomes of medical science research to help people live safe and healthy lives
The Soiken Group began as a bioventure originating from the Faculty of Medicine at Osaka University. With a focus on biomarker technologies, we provide tests for the clinical evaluation of…
Building on the evidence gained using the biomarker technology originating from Osaka University, the Soiken Group strives to keep medical costs down and improve people's lifestyles…
Business Strategy, Business Model
The focus of the Soiken Group's research is the development of biomarkers and related bioassay systems that can be used to objectively and quantitatively evaluate the state of diseases…
"Evidence" is our keyword as we create synergy in all areas of the Soiken Group. The key concept for the Soiken Group is evidence based on biomarker technology…
The Soiken Group is a bioventure originating in Osaka University that was founded by Director Osami Kajimoto in July 1994 to contribute to the research and development of new pharmaceutical drugs and functional foods…